We elected to assess HSD11B2 promoter DNA methylation by bisulfite pyrosequencing in our nIUGR cohort, targeting 11 consecutive CpG sites including four CpG sites previously associated with birth weight across normal ranges and increased DNA methylation in IUGR cases [52]. This evidence concerns the gene HSD11B2 and fetal growth restriction.